Phone apps aim to shield melanoma survivors from harmful UV rays
NCT ID NCT07556380
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study tests five different smartphone programs designed to help melanoma survivors reduce unprotected sun exposure. About 150 participants will wear a UV sensor and activity monitor, complete daily surveys, and use the programs for 8 weeks. The goal is to see which programs are easiest to use and most effective at preventing sun damage and future skin cancers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 150 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2025
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Is able to speak, read and write in English * Had previous melanoma diagnosis with no melanoma treatment in the last three months * Has no current Melanomas or untreated skin cancer * Reports spending at least 15 minutes outside per day during Spring/ Summer on both weekdays and weekends * Owns a smartphone with access to both Bluetooth and WIFI * Is willing to use the UV device and Actigraph during waking hours * Is willing to download and use a study app * Is willing to actively participate in the study for up to 1 year Exclusion Criteria: * Has a medical condition preventing moderate-to-vigorous physical activity (MVPA) or a doctor recommendation to avoid MVPA * Is currently enrolled in another study on MVPA
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Melanoma (skin cancer) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Huntsman Cancer Institute at The University of Utah
RECRUITINGSalt Lake City, Utah, 84112, United States
-
Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sun on the job: nationwide study maps skin cancer in outdoor workers
- Blood test could tell melanoma patients when to stop immunotherapy
- Your gut bacteria may hold the key to whether immunotherapy works
- Can a DNA vaccine teach the immune system to hunt melanoma?
- Can protein patterns in stored tumors point to new treatment targets?
- Can a new PET tracer light up hidden cancers?